482 related articles for article (PubMed ID: 20108112)
1. Integrating the multiple dimensions of genomic and epigenomic landscapes of cancer.
Chari R; Thu KL; Wilson IM; Lockwood WW; Lonergan KM; Coe BP; Malloff CA; Gazdar AF; Lam S; Garnis C; MacAulay CE; Alvarez CE; Lam WL
Cancer Metastasis Rev; 2010 Mar; 29(1):73-93. PubMed ID: 20108112
[TBL] [Abstract][Full Text] [Related]
2. An integrative multi-dimensional genetic and epigenetic strategy to identify aberrant genes and pathways in cancer.
Chari R; Coe BP; Vucic EA; Lockwood WW; Lam WL
BMC Syst Biol; 2010 May; 4():67. PubMed ID: 20478067
[TBL] [Abstract][Full Text] [Related]
3. SIGMA2: a system for the integrative genomic multi-dimensional analysis of cancer genomes, epigenomes, and transcriptomes.
Chari R; Coe BP; Wedseltoft C; Benetti M; Wilson IM; Vucic EA; MacAulay C; Ng RT; Lam WL
BMC Bioinformatics; 2008 Oct; 9():422. PubMed ID: 18840289
[TBL] [Abstract][Full Text] [Related]
4. Integration of genome scale data for identifying new players in colorectal cancer.
Sokolova V; Crippa E; Gariboldi M
World J Gastroenterol; 2016 Jan; 22(2):534-45. PubMed ID: 26811605
[TBL] [Abstract][Full Text] [Related]
5. Highly parallel genomic assays.
Fan JB; Chee MS; Gunderson KL
Nat Rev Genet; 2006 Aug; 7(8):632-44. PubMed ID: 16847463
[TBL] [Abstract][Full Text] [Related]
6. Understanding genomic alterations in cancer genomes using an integrative network approach.
Wang E
Cancer Lett; 2013 Nov; 340(2):261-9. PubMed ID: 23266571
[TBL] [Abstract][Full Text] [Related]
7. The promise of omics-based approaches to cancer prevention.
Meerzaman D; Dunn BK; Lee M; Chen Q; Yan C; Ross S
Semin Oncol; 2016 Feb; 43(1):36-48. PubMed ID: 26970123
[TBL] [Abstract][Full Text] [Related]
8. Whole genome profiling and other high throughput technologies in lymphoid neoplasms--current contributions and future hopes.
Campo E
Mod Pathol; 2013 Jan; 26 Suppl 1():S97-S110. PubMed ID: 23281439
[TBL] [Abstract][Full Text] [Related]
9. Microarray tools for deciphering complex diseases.
Shai RM
Front Biosci; 2006 May; 11():1414-24. PubMed ID: 16368525
[TBL] [Abstract][Full Text] [Related]
10. Integration of genomic technologies for accelerated cancer drug development.
Basik M; Mousses S; Trent J
Biotechniques; 2003 Sep; 35(3):580-2, 584, 586 passim. PubMed ID: 14513563
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic mapping and functional analysis in a breast cancer metastasis model using whole-genome promoter tiling microarrays.
Rodenhiser DI; Andrews J; Kennette W; Sadikovic B; Mendlowitz A; Tuck AB; Chambers AF
Breast Cancer Res; 2008; 10(4):R62. PubMed ID: 18638373
[TBL] [Abstract][Full Text] [Related]
12. Next-generation sequencing technologies for DNA methylation analyses in cancer genomics.
Boerno ST; Grimm C; Lehrach H; Schweiger MR
Epigenomics; 2010 Apr; 2(2):199-207. PubMed ID: 22121870
[TBL] [Abstract][Full Text] [Related]
13. New insights into the biology and origin of mature aggressive B-cell lymphomas by combined epigenomic, genomic, and transcriptional profiling.
Martín-Subero JI; Kreuz M; Bibikova M; Bentink S; Ammerpohl O; Wickham-Garcia E; Rosolowski M; Richter J; Lopez-Serra L; Ballestar E; Berger H; Agirre X; Bernd HW; Calvanese V; Cogliatti SB; Drexler HG; Fan JB; Fraga MF; Hansmann ML; Hummel M; Klapper W; Korn B; Küppers R; Macleod RA; Möller P; Ott G; Pott C; Prosper F; Rosenwald A; Schwaenen C; Schübeler D; Seifert M; Stürzenhofecker B; Weber M; Wessendorf S; Loeffler M; Trümper L; Stein H; Spang R; Esteller M; Barker D; Hasenclever D; Siebert R;
Blood; 2009 Mar; 113(11):2488-97. PubMed ID: 19075189
[TBL] [Abstract][Full Text] [Related]
14. Multi-Omics of Single Cells: Strategies and Applications.
Bock C; Farlik M; Sheffield NC
Trends Biotechnol; 2016 Aug; 34(8):605-608. PubMed ID: 27212022
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic regulation in cell reprogramming revealed by genome-wide analysis.
Hong CP; Park J; Roh TY
Epigenomics; 2011 Feb; 3(1):73-81. PubMed ID: 22126154
[TBL] [Abstract][Full Text] [Related]
16. Integrative genome-wide analyses reveal the transcriptional aberrations in Japanese esophageal squamous cell carcinoma.
Takemoto A; Tanimoto K; Mori S; Inoue J; Fujiwara N; Noda T; Inazawa J
Cancer Sci; 2021 Oct; 112(10):4377-4392. PubMed ID: 34263978
[TBL] [Abstract][Full Text] [Related]
17. High throughput approaches in neuroscience.
Morris CM; Wilson KE
Int J Dev Neurosci; 2004 Nov; 22(7):515-22. PubMed ID: 15465281
[TBL] [Abstract][Full Text] [Related]
18. Combining chromatin immunoprecipitation and oligonucleotide tiling arrays (ChIP-Chip) for functional genomic studies.
Eeckhoute J; Lupien M; Brown M
Methods Mol Biol; 2009; 556():155-64. PubMed ID: 19488877
[TBL] [Abstract][Full Text] [Related]
19. Microarray technology: beyond transcript profiling and genotype analysis.
Hoheisel JD
Nat Rev Genet; 2006 Mar; 7(3):200-10. PubMed ID: 16485019
[TBL] [Abstract][Full Text] [Related]
20. Lung cancer: from single-gene methylation to methylome profiling.
Heller G; Zielinski CC; Zöchbauer-Müller S
Cancer Metastasis Rev; 2010 Mar; 29(1):95-107. PubMed ID: 20099008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
